Form 4 · Filed Feb 3, 2026, 12:00 PM UTC
CNTA/Centessa Pharmaceuticals plc
Anderson Karen M. — Chief People Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 2, 2026 | A | other | 29,000 | $0 | — | 72,716 |
| Feb 2, 2026 | A | other | 117,000 | $0 | — | 117,000 |
| Feb 1, 2026 | F | other | 10,606 | $25 | $260,589 | 43,716 |
Source: SEC EDGAR raw filing ↗ · Accession 0001470831-26-000086